Impact of Follow-Up by The Primary Care Or Specialist Physician on Pediatric Asthma Outcomes after An Emergency Department Visit: The Case of Montreal, Canada

2007 ◽  
Vol 20 (1) ◽  
pp. 23-35 ◽  
Author(s):  
Anna J. Koné P. ◽  
Michèle Rivard ◽  
Claudine Laurier
Keyword(s):  
Primary Care ◽  
Emergency Department ◽  
Emergency Department Visit ◽  
Pediatric Asthma ◽  
Specialist Physician ◽  
Asthma Outcomes

Insurance Status and Access to Urgent Primary Care Follow-up After an Emergency Department Visit in 2016

2018 ◽  
Vol 71 (4) ◽  
pp. 487-496.e1 ◽  
Author(s):  
Shih-Chuan Chou ◽  
Yanhong Deng ◽  
Jerry Smart ◽  
Vivek Parwani ◽  
Steven L. Bernstein ◽  
...  
Keyword(s):  
Primary Care ◽  
Emergency Department ◽  
Emergency Department Visit ◽  
Insurance Status

Parental Education on Asthma Severity in the Emergency Department and Primary Care Follow-up Rates

2013 ◽  
Vol 52 (7) ◽  
pp. 612-619 ◽  
Author(s):  
Kelli W. Williams ◽  
Carolyn Word ◽  
Maria R. Streck ◽  
M. Olivia Titus
Keyword(s):  
Primary Care ◽  
Emergency Department ◽  
Parental Education ◽  
Asthma Severity

scholarly journals Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR

10.36469/9905 ◽  
2015 ◽  
Vol 2 (2) ◽  
pp. 221-232
Author(s):  
Mike Durkin ◽  
Jacqueline Pesa ◽  
Jessica Lopatto ◽  
Rachel Halpern ◽  
Damon Van Voorhis ◽  
...  
Keyword(s):  
Emergency Department ◽  
Emergency Department Visit ◽  
Healthcare Costs ◽  
Index Date ◽  
Opioid Therapy ◽  
Care Utilization ◽  
Research Database ◽  
Before And After ◽  
Pain Patients

Background: The objective of this study was to compare health care utilization and costs between matched cohorts of chronic pain patients treated with the opioids tapentadol extended release (ER) or oxycodone controlled release (CR). Methods: This retrospective study used claims data from the Optum Research Database. Commercial and Medicare Advantage adult patients with ≥1 prescription fill for oxycodone CR or tapentadol ER between September 1, 2011 and September 30, 2012 were eligible. The date of the first observed oxycodone CR or tapentadol ER claim was the index date. Patients had continuous health plan enrollment for 6 months before and after the index date, ≥ 90 days supply of opioid therapy, and no index drug claims in the preindex period. Patients were propensity score matched in a 1:2 ratio (tapentadol ER : oxycodone CR). Results: The attributes of the matched cohorts (1,120 tapentadol ER and 2,240 oxycodone CR patients) appeared similar. In the 6 month post-index period, lower proportions of the tapentadol ER cohort than the oxycodone CR cohort had ≥1 inpatient stay (14.6% versus 20.5%; p<0.001) and ≥1 emergency department visit (33.4% versus 37.5%; p=0.021). The tapentadol ER compared with the oxycodone CR cohort had higher mean pharmacy costs ($4,263 versus $3,694; p <0.001), lower mean inpatient costs ($3,625 versus $6,309; p<0.001), and lower mean total healthcare costs ($16,510 versus $19,330; p=0.004). Conclusions: During follow-up, total mean healthcare costs were lower among tapentadol ER patients than oxycodone CR patients, and tapentadol ER patients were less likely to have an inpatient admission or emergency department visit.

Follow-up Care After an Emergency Department Visit for Asthma in a Pediatric Military Population: Clinical Interventions and Outcomes

CHEST Journal ◽  
2015 ◽  
Vol 148 (4) ◽  
pp. 674A
Author(s):  
Michael Smiley ◽  
Nick Sicignano ◽  
Elizabeth Allen ◽  
Rees Lee ◽  
Deena Chisolm
Keyword(s):  
Emergency Department ◽  
Emergency Department Visit ◽  
Military Population ◽  
Clinical Interventions ◽  
Follow Up Care

scholarly journals Primary care follow up of patients discharged from the emergency department: a retrospective study

2004 ◽  
Vol 5 (1) ◽  
Author(s):  
Shlomo Vinker ◽  
Eliezer Kitai ◽  
Yaacov Or ◽  
Sasson Nakar
Keyword(s):  
Primary Care ◽  
Emergency Department ◽  
Retrospective Study
Sign in / Sign up

Export Citation Format

Share Document